Ipsen and Skyhawk Therapeutics Announce Collaboration to Explore Rare Neurological Diseases Through RNA Targeting
Paris and Boston (ots/PRNewswire) – Ipsen (Euronext: IPN; ADR: IPSEY) and Skyhawk Therapeutics today announced the signing of an exclusive global collaboration to discover and develop novel small molecules that…